The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients
Farah Diba Begum, Claus K Høgdall, Susanne K Kjaer, Lise Christensen, Jan Blaakaer, Johannes E Bock, Eva Glud, Gunilla Høyer-Hansen, Helmer Ring-Larsen, Estrid V S Høgdall
35Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science